- Home
- NDLS vs TELA Comparison
NDLS vs TELA Comparison
Compare NDLS & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- TELA
- Stock Information
- Founded
- NDLS 1995
- TELA 2012
- Country
- NDLS United States
- TELA United States
- Employees
- NDLS N/A
- TELA N/A
- Industry
- NDLS Restaurants
- TELA Medical/Dental Instruments
- Sector
- NDLS Consumer Discretionary
- TELA Health Care
- Exchange
- NDLS Nasdaq
- TELA Nasdaq
- Market Cap
- NDLS 54.8M
- TELA 61.8M
- IPO Year
- NDLS 2013
- TELA 2019
- Fundamental
- Price
- NDLS $0.83
- TELA $2.92
- Analyst Decision
- NDLS Strong Buy
- TELA Strong Buy
- Analyst Count
- NDLS 2
- TELA 4
- Target Price
- NDLS $3.00
- TELA $9.25
- AVG Volume (30 Days)
- NDLS 253.5K
- TELA 431.0K
- Earning Date
- NDLS 11-06-2024
- TELA 11-07-2024
- Dividend Yield
- NDLS N/A
- TELA N/A
- EPS Growth
- NDLS N/A
- TELA N/A
- EPS
- NDLS N/A
- TELA N/A
- Revenue
- NDLS $495,817,000.00
- TELA $68,649,000.00
- Revenue This Year
- NDLS $0.11
- TELA $30.39
- Revenue Next Year
- NDLS $0.39
- TELA $25.29
- P/E Ratio
- NDLS N/A
- TELA N/A
- Revenue Growth
- NDLS N/A
- TELA 29.34
- 52 Week Low
- NDLS $0.80
- TELA $2.30
- 52 Week High
- NDLS $3.50
- TELA $7.84
- Technical
- Relative Strength Index (RSI)
- NDLS 27.15
- TELA 53.29
- Support Level
- NDLS $0.81
- TELA $2.90
- Resistance Level
- NDLS $1.04
- TELA $3.19
- Average True Range (ATR)
- NDLS 0.08
- TELA 0.19
- MACD
- NDLS -0.03
- TELA 0.01
- Stochastic Oscillator
- NDLS 6.09
- TELA 37.61
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.